This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Peganum harmala: Difference between revisions
>Oskykins No edit summary |
>Oskykins No edit summary |
||
| Line 3: | Line 3: | ||
==Pharmacology== | ==Pharmacology== | ||
[[File:Syrianrueseeds.jpg|150px|thumbnail|left|Syrian rue seeds]] | |||
Powdered syrian rue seeds act as a reversible inhibitor of MAO-A (RIMA) at doses of 2-5g. | Powdered syrian rue seeds act as a reversible inhibitor of MAO-A (RIMA) at doses of 2-5g. | ||
Syrian rue seeds contain several different harmala alkaloids at slightly varying percentages. Only some are monoamine oxidase A inhibitors. In one study, total harmala alkaloids were at least 5.9% of dried weight. | Syrian rue seeds contain several different harmala alkaloids at slightly varying percentages. Only some are monoamine oxidase A inhibitors. In one study, total harmala alkaloids were at least 5.9% of dried weight. | ||
| Line 12: | Line 13: | ||
*'''Vasicine (peganine): '''0.25%< | *'''Vasicine (peganine): '''0.25%< | ||
*'''Vasicinone:''' 0.0007% | *'''Vasicinone:''' 0.0007% | ||
==See also== | ==See also== | ||